Clinical Evaluation of the Efficacy of a Nasal Spray in the Treatment of Nasal Dryness

NCT07657247 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-06-18

No results posted yet for this study

Summary

The purpose of this study is to see whether the nasal spray can help improve hydration of the nasal mucosa, reduce discomfort linked to nasal dryness, and confirm its safety in patients suffering from nasal dryness.

Conditions

  • Nasal Dryness

Interventions

DEVICE

Spray pompe nasal

Dosage: 2 sprays per nostril

Sponsors & Collaborators

  • Eurofins

    collaborator INDUSTRY
  • YSLab

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-12-15
Primary Completion
2027-03-31
Completion
2027-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07657247 on ClinicalTrials.gov